Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reimbursement Effects on Enrollment in Obesity Treatment

This study has been completed.
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00250510
First received: November 7, 2005
Last updated: March 17, 2010
Last verified: March 2010
  Purpose

The purpose of this study is to simulate what would occur if insurance reimbursement became available for obesity treatment but required that the individual meet defined performance milestones.


Condition Intervention
Obesity
Behavioral: Simulated insurance reimbursement

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Prospective Study to Determine the Effects of a Reimbursement Incentive on Enrollment and Outcomes in a Community Weight Control Program.

Resource links provided by NLM:


Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Primary Outcome Measures:
  • Proportion of inquirers who enroll in obesity treatment [ Time Frame: 16 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Class attendance [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
  • Percent weight loss [ Time Frame: 12 weeks and 9 months ] [ Designated as safety issue: No ]
  • Changes in medication dosages and costs [ Time Frame: 12 weeks and 9 months ] [ Designated as safety issue: No ]
  • Visits to health care providers [ Time Frame: 12 weeks and 9 months ] [ Designated as safety issue: No ]

Enrollment: 401
Study Start Date: June 2004
Study Completion Date: December 2006
Arms Assigned Interventions
No Intervention: 1
Experimental: 2
EatRight Program inquirers with BMI's of 30 kg/m2 or greater were told that they would have the possibility of being reimbursed 50% ($150) of their initial fee ($300) if certain conditions were met.
Behavioral: Simulated insurance reimbursement
Participants were told they would have the possibility of being reimbursed 50% ($150) of their initial fee ($300) if they: 1) paid the fee in advance or committed 3 monthly payments in advance, 2) attended 10 of 12 class sessions, and 3) lost at least 6% of their current body weight during the program.

Detailed Description:

This is a prospective study to determine whether a reimbursement incentive (the prospect of reimbursement of half of the out-of-pocket fee for participation in the UAB EatRight Weight Management Program, when it is contingent upon consistent Program participation and loss of 6% of initial body weight) is associated with (1) a higher rate of Program enrollment and (2) greater percent weight loss, greater reductions in medication dosages and costs, and fewer visits to health care providers after 12 weeks and 9 months.

  Eligibility

Ages Eligible for Study:   19 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adults with obesity (BMI at least 30 kg/m2)
  • Commitment of the full EatRight Weight Management Program fee

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00250510

Locations
United States, Alabama
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35294-3360
Sponsors and Collaborators
Investigators
Principal Investigator: Douglas C Heimburger, MD University of Alabama at Birmingham
  More Information

Additional Information:
Publications:
Responsible Party: Jane Fant/Assoc VP for Sponsored Research Administration, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT00250510     History of Changes
Other Study ID Numbers: R03 DK67357 (completed)
Study First Received: November 7, 2005
Last Updated: March 17, 2010
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
Obesity treatment
Insurance reimbursement
Health care utilization
Health care costs

Additional relevant MeSH terms:
Obesity
Body Weight
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms

ClinicalTrials.gov processed this record on November 25, 2014